Rapid Aortic Measurements

K251987

iSchemaView, Inc. · cleared 2025-09-23 · product code QIH · Radiology

Premarket evidence — what FDA accepted

Device typesamd
source quote (p.5)
Rapid Aortic Measurements (AM) is a Software as a Medical Device (SaMD) image processing module and is part of the Rapid Platform.
AlgorithmAI/ML; traditional
source quote (p.8)
AI/ML; traditional
Adaptive (vs locked)FDA source did not state this
PCCPFDA source did not state this
Cybersecurity addressedYes
source quote (p.9)
Rapid Aortic Measurements has been designed to meet the cybersecurity requirements using design Vulnerability Assessments, SBOM's, and PEN Testing.

Validation studies (1)

Retrospective clinical

n=115 patients

endpoints: segmentation quality/clinical accuracy; CPR/MPR quality; anatomical labeling; maximum oblique diameter location accuracy; centerline accuracy; reproducibility of generating ground truths; mean absolute error (MAE)

standards: ISO 14971:2019, IEC 62304:2015, IEC 62366-1:2015 +A1:2020, NEMA PS 3.1 - 3.20, ISO 15223-1:2021, 21 CFR, Part 820.30

Reported performance (2 observations)

diceas written: “Dice coefficient (VR outputs)0.93
source quote (p.10)
For VR outputs, the primary endpoint passed with an average Dice coefficient of 0.93 and average Hausdorff distance of 0.54 mm.
diceas written: “Dice coefficient (reproducibility of generating ground truths)0.95
source quote (p.10)
The secondary endpoint, reproducibility of generating ground truths, showed an average Dice coefficient of 0.95, demonstrating strong reproducibility of ground truth segmentations.

Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.

Predicate network

Postmarket — what happened after clearance

0
recalls in product code, 24mo
3
MAUDE reports in code, 12mo
vs code's own 3-yr baseline
0
drift signals on this device

Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device). Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-07-08.

Reimbursement — how devices like this got paid

Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).

RIGOR™ Precedent · public FDA/CMS data · descriptive decision-support, not regulatory or reimbursement advice. Share this page: radar.healthai.com/precedent/device/K251987